Rua Bioscience (NZSE:RUA) Research & Development: NZ$0.98 Mil (TTM As of Dec. 2025)


What is Rua Bioscience Research & Development?

Rua Bioscience NZSE:RUA +3.57% Research & Development is NZ$0.98 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rua Bioscience's Research & Development for the six months ended in Dec. 2025 was NZ$0.53 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NZ$0.98 Mil.

Rua Bioscience  (NZSE:RUA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rua Bioscience Research & Development Related Terms

Rua Bioscience Research & Development Historical Data

* Premium members only.

The historical data trend for Rua Bioscience's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience Research & Development Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
0.32 2.98 1.59 1.18 0.95

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.56 0.62 0.49 0.45 0.53

Rua Bioscience Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NZ$0.98 Mil mean?
Rua Bioscience (NZSE:RUA) has a Research & Development of NZ$0.98 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Rua Bioscience and its competitors.
Is Rua Bioscience's Research & Development too high?
Rua Bioscience's current Research & Development is NZ$0.98 Mil.
How does Rua Bioscience's Research & Development compare to ZTS and UTHR?
Rua Bioscience's Research & Development of NZ$0.98 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rua Bioscience and its competitors. Rua Bioscience's current Research & Development is NZ$0.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Rua Bioscience (NZSE:RUA) has a current Research & Development of NZ$0.98 Mil. The current Research & Development is NZ$0.98 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current Research & Development is NZ$0.98 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rua Bioscience Business Description

Address 704 Te Araroa Road, RD3, Ruatoria, NZL, 4083
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.